(Q58447498)

Michael Taulo Lund

1

0 references

Flemming Dela

Flemming Dela

10

0 references

Jørn W. Helge

Jørn Wulff Helge

8

0 references

Jens Juul Holst

Jens Juul Holst

9

0 references

author name string

Merethe Hansen

2

0 references

Stinna Skaaby

3

0 references

Mikael Støckel

5

0 references

Andrea Karen Floyd

6

0 references

Karsten Bech

Preoperative fasting plasma C-peptide level may help to predict diabetes outcome after gastric bypass surgery

7

0 references

language of work or name

English

0 references

publication date

15 July 2015

0 references

published in

Journal of Physiology

0 references

volume

593

0 references

issue

14

0 references

page(s)

3123-33

0 references

cites work

1 reference

Preoperatively determinable factors predictive of diabetes mellitus remission following Roux-en-Y gastric bypass: a review of the literature

21 January 2018

1 reference

Early enhancements of hepatic and later of peripheral insulin sensitivity combined with increased postprandial insulin secretion contribute to improved glycemic control after Roux-en-Y gastric bypass

21 January 2018

1 reference

Weight loss and incretin responsiveness improve glucose control independently after gastric bypass surgery

21 January 2018

1 reference

Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis

21 January 2018

1 reference

Improvement in peripheral glucose uptake after gastric bypass surgery is observed only after substantial weight loss has occurred and correlates with the magnitude of weight lost

21 January 2018

1 reference

Hepatic and peripheral insulin sensitivity and diabetes remission at 1 month after Roux-en-Y gastric bypass surgery in patients randomized to omentectomy

21 January 2018

1 reference

Limited recovery of β-cell function after gastric bypass despite clinical diabetes remission

21 January 2018

1 reference

ISEC: a program to calculate insulin secretion.

21 January 2018

1 reference

Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects

21 January 2018

1 reference

GLP-1 action and glucose tolerance in subjects with remission of type 2 diabetes after gastric bypass surgery

21 January 2018

1 reference

Exaggerated glucagon-like peptide 1 response is important for improved β-cell function and glucose tolerance after Roux-en-Y gastric bypass in patients with type 2 diabetes.

21 January 2018

1 reference

Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance.

21 January 2018

1 reference

Acute effects of gastric bypass versus gastric restrictive surgery on beta-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes

21 January 2018

1 reference

Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes

21 January 2018

1 reference

Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes

21 January 2018

1 reference

Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass

21 January 2018

1 reference

Incretin hormone and insulin responses to oral versus intravenous lipid administration in humans.

21 January 2018

1 reference

Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

21 January 2018

1 reference

Bariatric surgery versus conventional medical therapy for type 2 diabetes

21 January 2018

1 reference

GLP-1 and changes in glucose tolerance following gastric bypass surgery in morbidly obese subjects.

21 January 2018

1 reference

Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans

21 January 2018

1 reference

Gastric bypass surgery enhances glucagon-like peptide 1-stimulated postprandial insulin secretion in humans

21 January 2018

1 reference

Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes

21 January 2018

1 reference

Bariatric surgery versus intensive medical therapy in obese patients with diabetes

21 January 2018

1 reference

Review of the key results from the Swedish Obese Subjects (SOS) trial - a prospective controlled intervention study of bariatric surgery

21 January 2018

1 reference

GLP-1 plays a limited role in improved glycemia shortly after Roux-en-Y gastric bypass: a comparison with intensive lifestyle modification

21 January 2018

1 reference

Psychological predictors of mental health and health-related quality of life after bariatric surgery: a review of the recent research

21 January 2018

1 reference

The psychological profile of bariatric patients with and without type 2 diabetes: baseline results of the longitudinal GASMITO-PSYC study.

21 January 2018

1 reference

Early and longer term effects of gastric bypass surgery on tissue-specific insulin sensitivity and beta cell function in morbidly obese patients with and without type 2 diabetes

21 January 2018

1 reference

The Role of β-Cell Function and Insulin Sensitivity in the Remission of Type 2 Diabetes after Gastric Bypass Surgery

21 January 2018

1 reference

Insulin sensitivity and secretion changes after gastric bypass in normotolerant and diabetic obese subjects

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25867961